Advisors Asset Management, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Advisors Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $1,082 - $4,485	-3,867 Reduced 25.4%	11,358 $3,000
Q1 2024 May 14, 2024	SELL	$1.06 - $1.67 $2,203 - $3,471	-2,079 Reduced 12.01%	15,225 $17,000
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $1,073 - $1,525	852 Added 5.18%	17,304 $29,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $13,187 - $22,557	11,568 Added 236.86%	16,452 $30,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.19 $3,756 - $6,854	3,130 Added 178.45%	4,884 $6,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $2,859 - $6,174	1,754 New	1,754 $2,000

48M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.5B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.